Thomas David Hull III Sells 721 Shares of Kewaunee Scientific (NASDAQ:KEQU) Stock

Kewaunee Scientific Corporation (NASDAQ:KEQU) CEO Thomas David Hull III sold 721 shares of the firm’s stock in a transaction that occurred on Tuesday, September 23rd. The stock was sold at an average price of $44.00, for a total transaction of $31,724.00. Following the sale, the chief executive officer owned 42,573 shares of the company’s stock, valued at $1,873,212. The trade was a 1.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Thomas David Hull III also recently made the following trade(s):

• On Wednesday, September 24th, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $43.62, for a total transaction of $43,620.00.
• On Friday, September 19th, Thomas David Hull III sold 773 shares of Kewaunee Scientific stock. The stock was sold at an average price of $45.34, for a total transaction of $35,047.82.
• On Thursday, September 18th, Thomas David Hull III sold 652 shares of Kewaunee Scientific stock. The stock was sold at an average price of $46.00, for a total transaction of $29,992.00.

Kewaunee Scientific Trading Down 0.8%

Shares of NASDAQ:KEQU opened at $43.48 on Friday. The stock has a market capitalization of $124.79 million, a price-to-earnings ratio of 10.53 and a beta of 0.75. Kewaunee Scientific Corporation has a 1-year low of $30.33 and a 1-year high of $71.33. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.63 and a current ratio of 2.32. The company has a 50 day moving average price of $53.39 and a 200 day moving average price of $45.47.

Kewaunee Scientific (NASDAQ:KEQU) last issued its earnings results on Wednesday, September 10th. The technology company reported $1.10 earnings per share for the quarter. The firm had revenue of $71.10 million during the quarter. Kewaunee Scientific had a net margin of 4.68% and a return on equity of 25.65%.

Institutional Investors Weigh In On Kewaunee Scientific

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in KEQU. Bank of America Corp DE lifted its position in Kewaunee Scientific by 2,605.9% in the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after buying an additional 443 shares in the last quarter. IFP Advisors Inc lifted its position in Kewaunee Scientific by 61.5% in the 1st quarter. IFP Advisors Inc now owns 945 shares of the technology company’s stock worth $37,000 after buying an additional 360 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in Kewaunee Scientific in the 2nd quarter worth approximately $60,000. Wedbush Securities Inc. purchased a new stake in Kewaunee Scientific in the 2nd quarter worth approximately $232,000. Finally, Morgan Dempsey Capital Management LLC lifted its position in Kewaunee Scientific by 41.8% in the 2nd quarter. Morgan Dempsey Capital Management LLC now owns 4,229 shares of the technology company’s stock worth $247,000 after buying an additional 1,247 shares in the last quarter. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.